Deutsche Bank delays Bally's bid to amend term loan - report

3 hours ago 1
Bally"s Casino in Chicago, IL.

Joe Hendrickson

Bally Corp.'s (NYSE:BALY) effort to amend part of a ~$1.9B debt facility hit a snag, according to a media report on Monday.

Deutsche Bank (NYSE:DB), the bank arranging the term-loan amendment, has postponed the amendment, Bloomberg News reported, citing people familiar with

Recommended For You

More Trending News

Read Entire Article
  1. Homepage
  2. Finance
  3. Deutsche Bank delays Bally's bid to amend term loan - report

Related

Ascendis Pharma struggles after report of Yorvipath patient death

Ascendis Pharma struggles after report of Yorvipath patient ...

13 minutes ago 0
Alcoa to collaborate with U.S., Australia on new gallium plant

Alcoa to collaborate with U.S., Australia on new gallium pla...

20 minutes ago 0
Here are the major earnings before the open Tuesday

Here are the major earnings before the open Tuesday

36 minutes ago 0
Genentech wins approval of lupus drug obinutuzumab

Genentech wins approval of lupus drug obinutuzumab

39 minutes ago 0
Gold price resumes upward march after one-day reprieve as trading volume tops record

Gold price resumes upward march after one-day reprieve as tr...

51 minutes ago 0
‘Sad, if not damning’: Cathie Wood blasts the proxy firms who say Elon Musk’s $1 trillion pay package is just too rich

‘Sad, if not damning’: Cathie Wood blasts the proxy firms wh...

57 minutes ago 0
Merck starts construction on $3B manufacturing plant in Virginia

Merck starts construction on $3B manufacturing plant in Virg...

1 hour ago 0
East West Bancorp Q3 2025 Earnings Preview

East West Bancorp Q3 2025 Earnings Preview

1 hour ago 0
PennyMac Financial Q3 2025 Earnings Preview

PennyMac Financial Q3 2025 Earnings Preview

1 hour ago 0
Chubb Q3 2025 Earnings Preview

Chubb Q3 2025 Earnings Preview

1 hour ago 0
KORE announces private placement, board change

KORE announces private placement, board change

1 hour ago 0
Cogent gains FDA Breakthrough Therapy status for bezuclastinib

Cogent gains FDA Breakthrough Therapy status for bezuclastin...

1 hour ago 0
Eason Technology receives NYSE American non-compliance letter

Eason Technology receives NYSE American non-compliance lette...

1 hour ago 0
Cleveland-Cliffs outlines multiyear OEM contracts and $425M asset sales while advancing rare earths initiative

Cleveland-Cliffs outlines multiyear OEM contracts and $425M ...

1 hour ago 0
Dynex Capital signals continued portfolio growth and strategic expansion with New York office amid $1.8B market cap milestone

Dynex Capital signals continued portfolio growth and strateg...

1 hour ago 0
Sunoco LP raises dividend by 1.3% to $0.9202

Sunoco LP raises dividend by 1.3% to $0.9202

1 hour ago 0
Core Scientific holders should reject CoreWeave bid, ISS says

Core Scientific holders should reject CoreWeave bid, ISS say...

1 hour ago 0
General Motors declares $0.15 dividend

General Motors declares $0.15 dividend

1 hour ago 0
W.R. Berkley Q3 earnings rise on solid underwriting and investment income growth

W.R. Berkley Q3 earnings rise on solid underwriting and inve...

1 hour ago 0
Wintrust Financial Non-GAAP EPS of $3.46 beats by $0.75

Wintrust Financial Non-GAAP EPS of $3.46 beats by $0.75

1 hour ago 0

Trending

1. stranger things
2. हिंदी
3. cx
4. iran
5. dhanush
6. kiara advani
7. ritu kumar
8. rajesh khanna
9. e
10. karen khachanov

Popular

Gold ETFs see 6-fold jump in September inflows: What's driving surge?

Gold ETFs see 6-fold jump in September inflows: What's ...

5 days ago 7
GoodRx launches subscription program for men's hair loss

GoodRx launches subscription program for men's hair loss

5 days ago 7
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© FBT Company 2025. All rights are reserved